Sonography and Ovarian Tumors Professor Galal Lotfi Obstetrics & Gynecology Suez Canal University. Egypt.

Slides:



Advertisements
Similar presentations
Helical CT Screening for Lung Cancer at Advanced Radiology Consultants
Advertisements

WHAT IS THE TRUTH?.
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Cancer – Cell Division Gone Wrong
Endometriosis and Cancer…Is there a Causal Link? Paula Payton Masters Project 2/22/06 Advisor: Prof Eileen VanDyke.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Endometrial Cancer Screening for Cancer in Women.
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Ovary.
Breast Imaging Made Brief and Simple
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Reproductive health. Cancer Definition Cancer Definition The abnormal growth of cells without normal control of body. Types of Cancer  Malignant Cancer.
Ovarian cysts in Primary Care. When to refer? Physiological/pathological Benign/malignant Surgical approach? Open or keyhole? Do I need to do anything?
Approach to the Patient with a Pelvic Mass Karen Carlson, MD Assistant Professor Department of Obstetrics and Gynecology.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Eleni Galani Medical Oncologist
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Approach to a thyroid nodule
Dr Matt Hewitt Prophylactic Bilateral Salpingoophorectomy.
Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,
Ovarian Tumours Max Brinsmead MBBS PhD November 2014.
UOG Journal Club: January 2013
Ovarian Pathology for Undergraduates Max Brinsmead MB BS PhD November 2014.
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Russell A. Patterson Affiliation: Uniformed Services University.
Management of ovarian cysts
A prospective U.S. ovarian cancer screening study using the risk of ovarian cancer algorithm (ROCA) K. H. Lu, S. J. Skates, T. B. Bevers, W. Newland, R.
Endometrial Carcinoma
CASE: BREAST CANCER Alegre. Almora. Alonzo. Amaro. Amolenda. Anacta. Andal. Ang. Ang. Ang.
Imaging examinations of breasts
وما أوتيتم من العلم إلا قليلاً. Prepared by: Abdo A Elfiky.
How will you approach the 35-year old, with a 2x2x2cm, firm, mobile, well-circumscribed non-tender mass on her R breast?
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan.
Follow-up scans later in pregnancy improved accreta detection but provided useful information in only a limited number of cases. Of the individual markers,
Postmenopausal bleeding
FDG PET/CT case report early detection of ovarian cancer NM case conference, chairman: Nan-Jing Peng, MD.
Cytologic and DNA- Cytometric Early Diagnosis of Oral Cancer Torsten W. Remmerbach, Horst Weidenbach, Natalja Pomjanski, Kristiane Knops, Stefanie Mathes,
Gynecological Malignancies. Gynecologic malignancies account for 15% of all cancers in women. Gynecologic malignancies account for 15% of all cancers.
1 Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor Dep. of.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Ovarian and Endometrial Cancer Using risk factors to help triage Adam Rosenthal PhD MRCOG Consultant Gynaecologist and Gynaecological Oncologist.
Tamoxifen associated changes
CLINICAL EPIDEMIOLOGY III: JOURNAL APPRAISAL Group 3 February 11, 2010.
Vol 1. Cancer in general Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.
Pregnancy related Breast Lesions
THIRD CLASSIFICATION OF MICROCALCIFICATION STAGES IN MAMMOGRAPHIC IMAGES THIRD REVIEW Supervisor: Mrs.P.Valarmathi HOD/CSE Project Members: M.HamsaPriya( )
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
SCREENING IN GYNECOLOGICAL CANCER Taravat Fakheri OB/GYN KUMS.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
INCIDENCE AND ULTRASONIC PICTURES OF THE OVARIAN PATHOLOGY IN BUFFALOES A. Ali and A. Kh. Abdel-Razek Dept. Theriogenology, Faculty of Veterinary Medicine,
Table 1. Showing some key studies that described the evolution of ultrasonography as a potential screening tool for ovarian cancer Chukwuemeka Anthony.
Gynecologic Oncology New or Old subspecialty Samir Fouad Khalaf Professor OBGYN Al-Azhar University President
Sonography of ovarian masses Dr. Mohammed Abdalla Egypt, Domiat General Hospital.
Cancer prevention and early detection
Screening for Ovarian Cancer
Ovarian cysts and neoplasms in infant , children and adolescents
Indications for Breast MR Imaging
COMPARISON OF RISK OF MALIGNANCY INDICES AND ASSESSMENT OF DIFFERENT NEOPLASIAS IN THE ADNEXA (ADNEX) MODEL AS PREOPERATIVE MALİGNANCY EVALUATION METHODS.
Gynecological Oncology
Screening for Ovarian Cancer
Male and Female Reproductive Health Concerns
The postmenopausal bleeding (PMB)
Survivors Teaching Students: Saving Women’s LivesSM
Ultrasonographic Imaging of Ovarian Masses
VALUES OF ELASTOGRAPHY IN DIAGNOSIS OF THYROID CANCER
UOG Journal Club: August 2013
Presentation transcript:

Sonography and Ovarian Tumors Professor Galal Lotfi Obstetrics & Gynecology Suez Canal University. Egypt

Introduction The incidence of ovarian carcinoma has increased and is now the commonest malignancy of the female genital tract in much of the western world( William's 1992). Ovarian cancer presents in its late stages, (75% of ovarian cancer); Killing more women than does cancer of the cervix and uterine body combined (Silverberg et al l990).

Introduction… Ovarian cancer screening tests are the subject of endless debate. Some say it may progress to a late stage so quickly as to make screening impractical. This could be minimized by decreasing the time between follow up tests especially in women with family history of ovarian cancer. Again, this criticism could be said to any other screening programs. The screening tests tried for ovarian cancer included variety of techniques. Clinical examination, culdocentesis, immunoscintigraphy, tumor marker but all are insensitive.

Aim of Our Work Ultrasound has been an efficient tool for studying structural changes associated with human follicular development and ovulation, it was therefore a logical step to use the same technology for morphological changes in the ovary that may suggest the presence of early ovarian cancer. The use of ultrasound as a screening device for ovarian cancer was first proposed by Campbell et al (1982). The aim of that work was to implement a screening test to decrease the incidence of advancing ovarian carcinoma.

Material And Methods. 198 women who were postmenopausal. TVS for all women. Ovaries were classified with a score according to morphological and structural ultrasonic appearance on both sides. The TVS score (combined to both ovaries) was added to the clinical score, according to the woman's history, to get the total score. Another scan after a year was carried out for all women.

AppearanceScore Atrophic0 Volume >8cm.1 Simple anechoic <3cm1 Simple anechoic <5cm2 Simple anechoic >5cm3 Multilocular <5cm2 Multilocular >5cm3 Complex, cyst with echoic shadows.4 Solid cyst (solid areas >50%)5 Table (1) Scoring for US appearance of ovaries

Table (2), Score for Women’s History HistoryScore Family history of ovarian carcinoma2 Past or family history of genital, breast or colon 1 Negative history of oral contraceptive1 Nulligravida1

Table(3), Scoring of women, 1 st Scan Result TVS finding TVS score Other Ovary Family History Malignant History OCP History Total Score Simple cyst < 3cm (Persistent) 1$02014 Simple cyst < 5cm Simple cyst =>5cm Multiloc < 5cm Multiloc =>5cm 2$22017 Complex 2$00103 Solid

Table (4): Surgical Results of Cases Operated Upon After the First Examination (N=198). TVS resultNo.Result Volume > 8Cm31Not operated Simple cyst < 3cm (persistent)41 Malignant 3 Benign Simple cyst < 5cm52 Malignant 1 inflammatory 2Benign Simple cyst =>5cm33 simple serous Multilocucyst < 5cm1Inflammatory Multilocular cyst =>5cm21 malignant 1 inflammatory Complex cyst1Malignant Solid cyst1Malignant Total18

Table (5): cases with proved malignancy. TVSSurgical stage Path. Grade Pathology Simple cyst < 3cm 1aiICystadenocarcinoma Simple <5cm1aiIMucinous carcinoma Simple <5cm1aiiICystadenocarcinoma Multiloc. >5cm1biIIEndometroid Complex1aiICystadenocarcinoma Solid cyst1cIEndometroid

Table (6): Surgical results after one year (N 185) TVS Result No.Surgical result Volume >8cm31Not operated Simple Cyst < 3cm (persistent) 2Simple serous Simple < 5cm2Simple serous Simple cyst => 5cm0 Multilocular cyst <5cm0 Multilocular cyst =>5cm0 Complex cyst0 Solid cyst0 Total5

Table(7), Scoring of women after one year, N (185) TVS findingTVS score Other Ovary Family History Malignant History OCP History Total Score Simple cyst < 3cm (Persistent) Simple cyst < 5cm

Table (8): Comparison Between Cases With Proved Malignancy and Cases With Benign Lesions (first Scan). LesionNo.Min Score Max score MeanSD Malignant Benign

Mean and SD of total score of Benign and malignant lesions (first scan)

Detection of abnormal, benign and malignant lesion (first Scan) in 1 st scan

Detection of Abnormal, Benign and malignant lesion in 2 nd scan.

Conclusion Abnormal ovarian conditions detection rate was 9. 1% and 2.2% of cases in initial examination and subsequent year follow up. Malignant detection rate was 3%.

Conclusion Andolf & Jorgensen (1989) found no malignancy in 58 anechoic lesions less than 5cm as detected by ultrasound. Rodrigenz et al (1988) reported 3 cancers detected in simple cystic lesions with a diameter greater than 5cm. In the present study, small cysts were found to be not immune for malignancy, 3 cases with cyst diameter less than 3cmwere found to be malignant.

Epilog. With small cyst and in situations where we are in doubt, the implemented score could help in deciding up. For big, multilocular, complex or solid cysts, the answer is straight forward, surgical intervention. TVS, cheap compared to other imaging techniques, non invasive, seems to provide a simple screening technique for early ovarian cancer.

Epilog. Its strength resides in its high sensitivity 62.5%, however we cannot deny the false positive rates which is present in any diagnostic tool. Till we find another test with the least false positive results, TVS should be appreciated as a screening tool for such a lethal disease not only for susceptible women with family history or history of other malignancies but for the whole population.

Epilog.. Application of the suggested scoring system could help in differentiating between benign and malignant lesions.. The new advances in ultrasonography may enable us to better understand and recognize the earliest stages of oncogenesis with the ovary.